BioSpace Collaborative

Academic/Biomedical Research
News & Jobs
Biotechnology and Pharmaceutical Channel Medical Device and Diagnostics Channel Clinical Research Channel BioSpace Collaborative    Job Seekers:  Register | Login          Employers:  Register | Login  

NEWSLETTERS
Free Newsletters
Archive
My Subscriptions

NEWS
News by Subject
News by Disease
News by Date
PLoS
Search News
Post Your News
JoVE

CAREER NETWORK
Job Seeker Login
Most Recent Jobs
Search Jobs
Post Resume
Career Fairs
Career Resources
For Employers

HOTBEDS
Regional News
US & Canada
  Biotech Bay
  Biotech Beach
  Genetown
  Pharm Country
  BioCapital
  BioMidwest
  Bio NC
  BioForest
  Southern Pharm
  BioCanada East
  C2C Services & Suppliers™
Europe
Asia

DIVERSITY

PROFILES
Company Profiles

INTELLIGENCE
Research Store

INDUSTRY EVENTS
Research Events
Post an Event
RESOURCES
Real Estate
Business Opportunities

 News | News By Subject | News by Disease News By Date | Search News
Get Our Industry eNewsletter FREE email:    
   

Interpublic Pays Up to $78 Million for UK Double Helix


6/26/2012 9:00:42 AM

LONDON, NEW YORK, PHILADELPHIA and SINGAPORE, June 25, 2012 -- /PRNewswire/ -- McCann Health, a division of Interpublic Group (NYSE: IPG), announced today the acquisition of Double Helix. Founded in 1995, Double Helix is a leading, global provider of Market Research and Market Access services to the pharmaceutical and medical device industries. Dr. Wayne Phillips, who founded and runs Double Helix, will continue as CEO of Double Helix, reporting to John Cahill, CEO of McCann Health.

Mr. Cahill said, "For some time, we have been working to elevate all of our offerings by several orders of magnitude. With Double Helix, we now have the basis for the best market research and market access offerings in the business."

Double Helix rounds out McCann Health's impressive suite of services. Its focus on innovation and novel collaborations within its network makes McCann Health the most differentiated and endowed, full-service global healthcare communications company.

Dr. Phillips said, "The arrival of the right partner allows us to leverage our strong reputational position. McCann Health provides us with the resources to create an exciting and fulfilling future through the continued development and further internationalisation of the business."

Double Helix's Market Research division specialises in primary market research for its healthcare clients. The division focuses on the strategic and tactical business needs clients face throughout a product's lifecycle, from pre-clinical to post-launch. The division employs a wide range of qualitative and quantitative techniques to address diverse business objectives, primarily centred on scenario-planning, positioning, communications, market understanding and creative insights.

Double Helix's Market Access Consulting division assists clients to optimise the life cycle position of products in markets. Market Access consulting is the co-ordinated analysis of a number of inter-related activities, including: pricing, reimbursement, health economics and payer decision making-- pre-requisites for the successful launch of a product or therapy and its long-term profit maximisation.

With four offices strategically located in London, New York, Philadelphia, and Singapore, Double Helix not only specialises in the established markets of the US and Europe, but also focuses on emerging markets, providing clients with a truly global perspective. In the past year, Double Helix has performed projects across more than 40 countries for over 30 major pharmaceutical multinational clients.

About McCann Health: Comprising the world's most connected health and wellness experts, McCann Health is the most awarded professional and consumer health communications network with the largest international expertise spanning 35 countries and 61 offices. McCann Health's global network includes McCann HumanCare, McCann Healthcare, McCann Regan Campbell Ward, McCann Torre Lazur-- as well as the leading worldwide medical communications and consultancy practice, McCann Complete Medical. McCann Health is a part of McCann Worldgroup, the largest marketing communications agency network in the world, and is a leading healthcare agency network owned by Interpublic Group [NYSE: IPG].

SOURCE McCann Health


Read at Reuters
Read at BioSpace.com
Read at RTT News

   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES
 

//-->